Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.

BACKGROUND Merkel cell carcinoma (MCC) is an aggressive skin cancer with a mortality of 33%. Advanced disease at diagnosis is a poor prognostic factor, suggesting that earlier detection may improve outcome. No systematic analysis has been published to define the clinical features that are characteristic of MCC. OBJECTIVE We sought to define the clinical characteristics present at diagnosis to identify features that may aid clinicians in recognizing MCC. METHODS We conducted a cohort study of 195 patients given the diagnosis of MCC between 1980 and 2007. Data were collected prospectively in the majority of cases, and medical records were reviewed. RESULTS An important finding was that 88% of MCCs were asymptomatic (nontender) despite rapid growth in the prior 3 months (63% of lesions) and being red or pink (56%). A majority of MCC lesions (56%) were presumed at biopsy to be benign, with a cyst/acneiform lesion being the single most common diagnosis (32%) given. The median delay from lesion appearance to biopsy was 3 months (range 1-54 months), and median tumor diameter was 1.8 cm. Similar to earlier studies, 81% of primary MCCs occurred on ultraviolet-exposed sites, and our cohort was elderly (90% >50 years), predominantly white (98%), and often profoundly immune suppressed (7.8%). An additional novel finding was that chronic lymphocytic leukemia was more than 30-fold overrepresented among patients with MCC. LIMITATIONS The study was limited to patients seen at a tertiary care center. Complete clinical data could not be obtained on all patients. This study could not assess the specificity of the clinical characteristics of MCC. CONCLUSIONS To our knowledge, this study is the first to define clinical features that may serve as clues in the diagnosis of MCC. The most significant features can be summarized in an acronym: AEIOU (asymptomatic/lack of tenderness, expanding rapidly, immune suppression, older than 50 years, and ultraviolet-exposed site on a person with fair skin). In our series, 89% of primary MCCs had 3 or more of these findings. Although MCC is uncommon, when present in combination, these features may indicate a concerning process that would warrant biopsy. In particular, a lesion that is red and expanding rapidly yet asymptomatic should be of concern.

[1]  M. Weinstock,et al.  Adjuvant local irradiation for Merkel cell carcinoma. , 2006, Archives of dermatology.

[2]  M. Naraynan,et al.  Carcinoma metastasis to unexpected synchronous lymphoproliferative disorder: report of three cases and review of literature , 2003, Journal of clinical pathology.

[3]  R. W. Miller,et al.  Merkel cell carcinoma and melanoma: etiological similarities and differences. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  J. Barroeta,et al.  Merkel cell carcinoma and chronic lymphocytic leukemia (collision tumor) of the arm: A diagnosis by fine‐needle aspiration biopsy , 2007, Diagnostic cytopathology.

[5]  P. Nghiem,et al.  Merkel cell carcinoma: more deaths but still no pathway to blame. , 2007, The Journal of investigative dermatology.

[6]  H. Goepfert,et al.  Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. , 1984, Archives of otolaryngology.

[7]  P. Ziprin,et al.  Two cases of Merkel cell tumour arising in patients with chronic lymphocytic leukaemia , 2000, The British journal of dermatology.

[8]  H. Kerl,et al.  T1796A BRAF mutation is absent in Merkel cell carcinoma , 2005, The British journal of dermatology.

[9]  P. Nghiem,et al.  Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. , 2006, Archives of dermatology.

[10]  S. Baylin,et al.  Hedgehog Signaling: Progenitor Phenotype in Small-Cell Lung Cancer , 2003, Cell cycle.

[11]  M. Friedlaender,et al.  Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. , 2002, Transplantation.

[12]  M. First,et al.  Merkel's cell carcinoma in organ recipients: report of 41 cases. , 1999, Transplantation.

[13]  J. Ellenhorn,et al.  Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Stephen B. Baylin,et al.  Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer , 2003, Nature.

[15]  Nicole C Hodgson,et al.  Merkel cell carcinoma: Changing incidence trends , 2005, Journal of surgical oncology.

[16]  L. Clegg,et al.  Epidemiology of primary Merkel cell carcinoma in the United States. , 2003, Journal of the American Academy of Dermatology.

[17]  P. Nghiem,et al.  Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. , 2007, Journal of the American Academy of Dermatology.

[18]  K. Papageorgiou,et al.  A case repot of Merkel cell carcinoma on chronic lymphocytic leukemia: differential diagnosis of coexisting lymphadenopathy and indications for early aggressive treatment , 2005, BMC Cancer.

[19]  R. Alloway,et al.  Immunosuppression and Merkel cell cancer. , 2002, Transplantation proceedings.

[20]  J. Goedert,et al.  Merkel cell carcinoma and HIV infection , 2002, The Lancet.

[21]  Howard Y. Chang,et al.  Learning more from microarrays: insights from modules and networks. , 2005, The Journal of investigative dermatology.

[22]  T. Woodlock,et al.  Merkel cell carcinoma after chronic lymphocytic leukemia: case report and literature review. , 2003, American journal of clinical oncology.

[23]  R. Stern,et al.  Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. , 1998, The New England journal of medicine.

[24]  D. Coit,et al.  Merkel cell carcinoma: prognosis and treatment of patients from a single institution. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.